159 related articles for article (PubMed ID: 31537869)
21. Synthesis and evaluation of an
Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
[TBL] [Abstract][Full Text] [Related]
22. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
23. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
24. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
[TBL] [Abstract][Full Text] [Related]
25. (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging.
Pourghiasian M; Liu Z; Pan J; Zhang Z; Colpo N; Lin KS; Perrin DM; Bénard F
Bioorg Med Chem; 2015 Apr; 23(7):1500-6. PubMed ID: 25757604
[TBL] [Abstract][Full Text] [Related]
26. High-Contrast CXCR4-Targeted
Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
[TBL] [Abstract][Full Text] [Related]
27. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
28. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
29. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
30. "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.
Martin ME; Sue O'Dorisio M; Leverich WM; Kloepping KC; Walsh SA; Schultz MK
Recent Results Cancer Res; 2013; 194():149-75. PubMed ID: 22918759
[TBL] [Abstract][Full Text] [Related]
31. Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma.
Gao F; Sihver W; Jurischka C; Bergmann R; Haase-Kohn C; Mosch B; Steinbach J; Carta D; Bolzati C; Calderan A; Pietzsch J; Pietzsch HJ
Amino Acids; 2016 Mar; 48(3):833-847. PubMed ID: 26643502
[TBL] [Abstract][Full Text] [Related]
32. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
33. Alpha-melanocyte stimulating hormone peptide-targeted melanoma imaging.
Miao Y; Quinn TP
Front Biosci; 2007 May; 12():4514-24. PubMed ID: 17485393
[TBL] [Abstract][Full Text] [Related]
34. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.
Raposinho PD; Correia JD; Alves S; Botelho MF; Santos AC; Santos I
Nucl Med Biol; 2008 Jan; 35(1):91-9. PubMed ID: 18158948
[TBL] [Abstract][Full Text] [Related]
35. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
36. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
[TBL] [Abstract][Full Text] [Related]
37. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
38. Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging.
Zhang X; Yue Z; Lu BY; Vazquez-Flores GJ; Yuen J; Figueroa SD; Gallazzi F; Cutler C; Quinn TP; Lacy JL
Curr Radiopharm; 2012 Oct; 5(4):329-35. PubMed ID: 22724422
[TBL] [Abstract][Full Text] [Related]
39. The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH.
Teixeira V; Fernández M; Oddone N; Zhang X; Gallazzi F; Cerecetto H; Gambini JP; Porcal W; Cabral P; Quinn TP
Anticancer Agents Med Chem; 2017; 17(8):1144-1152. PubMed ID: 27924732
[TBL] [Abstract][Full Text] [Related]
40. Development of a (99m)Tc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors.
Shamshirian D; Erfani M; Beiki D; Fallahi B; Shafiei M
Ann Nucl Med; 2015 Oct; 29(8):709-20. PubMed ID: 26152564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
